Related Experiment Video
Updated: Jul 4, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
[Smoking and schizophrenia: epidemiological and clinical features]
1Service d'Addictologie, centre hospitalier Sainte-Anne, 1 rue Cabanis, Paris, France. a.dervaux@ch-ste-anne.fr
Patients with schizophrenia have significantly higher smoking rates than the general population, leading to increased cardiovascular risks. Nicotine may offer temporary relief for cognitive deficits and negative symptoms in schizophrenia patients.
Area of Science:
- Psychiatry
- Neuroscience
- Public Health
Background:
- Schizophrenia patients exhibit substantially higher cigarette smoking prevalence (60-90%) compared to the general population (23-30%).
- Despite declining smoking rates in the general population, prevalence remains high among individuals with schizophrenia, who also smoke more intensely.
- This elevated smoking contributes to reduced life expectancy and a significantly increased risk of cardiovascular disease in schizophrenia patients.
Purpose of the Study:
- To investigate the high prevalence of smoking in schizophrenia patients.
- To examine the impact of smoking on health outcomes, including cardiovascular disease and cancer risk.
- To explore the potential role of nicotine in alleviating cognitive deficits and negative symptoms associated with schizophrenia.
Main Methods:
- Comparative analysis of smoking prevalence data between schizophrenia patients and the general population.
- Review of studies on the health consequences of smoking in schizophrenia, focusing on mortality and disease risk.
- Examination of research investigating the effects of nicotine administration on cognitive function and symptoms in schizophrenia.
Main Results:
- Schizophrenia patients smoke more frequently and deeply than controls, increasing exposure to harmful substances.
- High smoking rates are strongly linked to a six-fold increase in cardiac deaths and other cardiovascular diseases.
- Nicotine may transiently improve certain cognitive deficits, such as sensory gating and working memory, and alleviate negative symptoms by modulating neurotransmission.
Conclusions:
- High smoking rates in schizophrenia patients represent a critical public health issue, exacerbating mortality risks, particularly from cardiovascular disease.
- While nicotine may offer symptomatic relief for cognitive and negative symptoms, its use is overshadowed by the severe health detriments of continued smoking.
- Further research is needed to develop effective smoking cessation strategies and alternative treatments for schizophrenia symptoms that do not carry the risks associated with tobacco use.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Schizophrenia
Stress Prevention and Stress Management Techniques IV

